The markets recovered in late afternoon trading to close modestly higher with the Dow adding 5 points to 21,012 as crude oil prices rose. Nasdaq edged up a point to 6,102.
On the upside
Inpixon (Nasdaq: INPX) received a purchase order of approximately $2.5 million from a leading Fortune 500 health insurer to design and deploy a highly modernized infrastructure platform for the insurer's core commercial claims processing application.
Elliott Management acquired a 15.3% stake in Gigamon (NYSE: GIMO).
Kosmos Energy (NYSE: KOS) announced a major discovery of gas off the coast of Senegal.
On the downside
PTC Therapeutics (Nasdaq: PTCT) reported a loss for the first quarter and announced that its Duchenne muscular dystrophy treatment Emflaza will be priced at $35,000 per year, well below the $89,000 annual price that was announced by Marathon Pharmaceuticals which previously owned Emflaza.
Investors locked in profits on Workhorse Group (Nasdaq: WKHS).
Shares of Amplify Snack Brands (NYSE: BETR) fell ahead of its earnings release tomorrow.
The broader S&P 500held steady at 2,399. Bitcoin leaped $107 to $1620.
